NYSE : INT

World Fuel Services Corporation — News

$24.26 USD

$0.17 (0.71%)

Volume
365.11K
Average Volume
544K
Market Capitalization
$1.51B
P/E Ratio
-7.58
Dividend Yield
2.23%
Price Target
Year High
$30.65
Year Low
$19.41
Day High
Day Low
Payout Ratio
-$0.18
Current Ratio
$1.06
Source Headline
Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6

Late-stage clinical studies advancing in soft tissue sarcoma and presurgical triple-negative breast cancer Over 200 patients enrolled in completed INT230-6 studies with a peer-reviewed paper published Active strategic partnering initiatives supported by maturing INT230-6 clinical and regulatory profile Strengthened balance sheet supporting disciplined clinical development strategy SHELTON, Conn., July 1, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase immune system recognition of cancers using its proprietary non-covalent conjugation technology, today provides a mid-year update highlighting the Company's late-stage development programs and growing strategic partnering focus for INT230-6.

prnewswire.com - 2026-07-01 08:00:00

Get INT Insider Trade Alerts

INT Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

INT Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2022-05-18 Stifel Upgrade Hold Buy
2022-01-20 B of A Securities Upgrade Underperform Buy